Modena University spin-out Holostem Advanced Therapies has secured clearance from the European Commission for stem-cell based eye therapy.
The decision marks a milestone for the use of stem cell therapies, which will be used by the Italy-based company to restore the eyesight of people who have suffered from severe cornea damage.
Clearance for the therapy has been twenty years in the making, and is specifically aimed at people who have damaged their corneas through chemical damage or other burns. Once…
